These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36075937)

  • 1. Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy.
    Solernó LM; Sobol NT; Gottardo MF; Capobianco CS; Ferrero MR; Vásquez L; Alonso DF; Garona J
    Sci Rep; 2022 Sep; 12(1):15058. PubMed ID: 36075937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
    Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
    BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.
    Liu L; Geng H; Mei C; Chen L
    Oxid Med Cell Longev; 2021; 2021():6661534. PubMed ID: 33859780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranilast enhances the effect of anticancer agents in osteosarcoma.
    Nakashima T; Nagano S; Setoguchi T; Sasaki H; Saitoh Y; Maeda S; Komiya S; Taniguchi N
    Oncol Rep; 2019 Jul; 42(1):176-188. PubMed ID: 31059083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts.
    Wang Y; Deng X; Yu C; Zhao G; Zhou J; Zhang G; Li M; Jiang D; Quan Z; Zhang Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):251. PubMed ID: 30326933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth.
    Sun F; Zhang Y; Xu L; Li S; Chen X; Zhang L; Wu Y; Li J
    Oncol Res; 2018 May; 26(4):655-664. PubMed ID: 29191257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
    Qu Y; Xia P; Zhang S; Pan S; Zhao J
    Oncol Rep; 2015 Mar; 33(3):1177-84. PubMed ID: 25572427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma.
    Gobin B; Huin MB; Lamoureux F; Ory B; Charrier C; Lanel R; Battaglia S; Redini F; Lezot F; Blanchard F; Heymann D
    Int J Cancer; 2015 Feb; 136(4):784-96. PubMed ID: 24961790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
    Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
    Wang Y; Fu Q; Zhao W
    Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.
    Higuchi T; Yamamoto J; Sugisawa N; Tashiro Y; Nishino H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Cancer Genomics Proteomics; 2020; 17(1):35-40. PubMed ID: 31882549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
    Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
    Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo anticancer effects of two quinoline-platinum(II) complexes on human osteosarcoma models.
    Ruiz MC; Resasco A; Di Virgilio AL; Ayala M; Cavaco I; Cabrera S; Aleman J; León IE
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):681-692. PubMed ID: 30661096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
    Tsai HC; Huang CY; Su HL; Tang CH
    PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
    Zhang W; Li Q; Song C; Lao L
    Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YM155 inhibits tumor growth and enhances chemosensitivity to cisplatin in osteosarcoma.
    Gao JZ; Chen FH; Wang L; Wei H; Meng SL
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2062-9. PubMed ID: 26125270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.